home · filing · 0001552033-23-000003
8-K
filed January 30, 2023, 6:59 PM ET
ticker TRU
CIK 0001552033
leadership
confidence high
sentiment neutral
materiality 0.45
TransUnion appoints Linda Zukauckas to board; Andrew Prozes to retire March 31
TransUnion
Linda Zukauckas, CFO of Nielsen Holdings, appointed as TransUnion director effective Jan 30, 2023.
Zukauckas will serve on the Audit Committee; board size increased to 12 then back to 11 upon Prozes retirement.
Andrew Prozes will retire from the board on March 31, 2023; not due to any disagreement with management.
Zukauckas brings experience from Nielsen, American Express, and Ally Financial; compensated per standard policies.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Linda K. Zukauckas
director
Effective 2023-01-30
Filed January 30, 2023, 6:59 PM ET
Linda K. Zukauckas was appointed by the Board as a director of TransUnion, effective January 30, 2023
Departed
Andrew Prozes
director
Effective 2023-03-31
Filed January 30, 2023, 6:59 PM ET
Andrew Prozes will not seek reelection as a director and will retire from the Board, effective March 31, 2023
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Linda K. Zukauckas was appointed as director at TransUnion.
Action appointed
Role director
Exact text from the filing
Linda K. Zukauckas was appointed by the Board as a director of TransUnion, effective January 30, 2023
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Andrew Prozes retired as director at TransUnion.
Action retired
Role director
Exact text from the filing
Andrew Prozes will not seek reelection as a director and will retire from the Board, effective March 31, 2023
View on SEC.gov
Source: SEC EDGAR
accession 0001552033-23-000003
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.